Rheumatology Practice with In-House Infusion And Imaging

This Orlando-based rheumatology practice offers a comprehensive range of clinical and diagnostic services under one roof, including consultations, biologic infusions, X-rays, bone density scanning, nerve studies, and phlebotomy. The facility operates within a 6,500 sq. ft. medical office, centrally located with strong referral patterns and accessible parking.

The practice generated approximately $4.9 million in revenue and over $1.6 million in SDE in 2024. Growth has been supported by consistent patient demand, integrated services, and a favorable payer mix. Infusion therapy represents a significant revenue driver, supported by in-house administration of six to seven high-yield biologic medications.

Team and Operations:
The team includes 1 board-certified rheumatologist (owner), 1 nurse practitioner, and 1 physician assistant, supported by 9 administrative and clinical staff. The staffing model is designed to accommodate an average of 34 patient visits per day across 255 clinic days per year. The current provider panel is sufficient to maintain current throughput with opportunity for expansion.

Patients and Services:
In 2024, the practice recorded ~8,400 patient visits, including over 1,000 new patients. Services include:

• Rheumatologic consultations
• In-house infusion (e.g., Cimzia, Orencia, Simponi)
• X-rays and bone density (DEXA) scans
• EMG/nerve conduction studies
• Phlebotomy

Payer relationships are stable, with most contracts reimbursing at or above Medicare rates and annual auto-renewals. The practice maintains a ~50% gross collections ratio on billed charges, aligned with rheumatology norms.

Real Estate Lease Option:
The practice operates from a physician-owned facility. A long-term lease is available at $15,000/month.

Reason for Sale & Transition Support
The owner is pursuing a planned transition and is seeking a partner or acquirer to take over operations. The seller will provide hands-on clinical and operational support post-close and is open to extending beyond two years under mutually agreeable terms.

Ideal Buyer:

• Experienced multi-site medical group or PE-backed platform seeking geographic or specialty expansion into
• Buyers with interest in infusion-based care models
• Operators seeking physician continuity during transition

By leveraging its integrated care model, experienced clinical team, and established patient base, the practice is well-positioned for continued success and expansion within the specialty care market. Opportunities to scale patient volume, optimize service mix, and deepen payer engagement offer a strong platform for future growth.